https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48708 Wed 29 Mar 2023 17:38:39 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48699 Wed 29 Mar 2023 11:20:40 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54554 Wed 28 Feb 2024 09:10:14 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54997 Wed 27 Mar 2024 16:38:22 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45241 Wed 26 Oct 2022 20:02:43 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45159 n = 5) or social workers (n = 2) under the direction of psychiatrists (n = 7). Care was primarily delivered in cancer centres (n = 5). Care co-ordinators advised primary care physicians (GPs) of medication changes (n = 3) but few studies (n = 2) actively involved GPs in medication prescribing and management. Conclusions: This review highlighted joint participation of GPs and specialist care physicians in collaborative care depression management is promoted but not achieved in cancer care. Current models reflect hospital-based multi-disciplinary models of care.]]> Wed 26 Oct 2022 19:31:07 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45253 n = 217) who visited the specialty outpatient clinic of four hospital departments. The survey was conducted using an iPad with answers sent automatically to a secure server. The survey included items about the participants' most feared diseases and the reasons behind those fears, estimates of dementia prevalence in Japan, and preferences regarding a diagnosis of dementia and the reasons for their preference. Results: The most feared disease was cancer (43.8 %), followed by dementia (18 %). Those selecting dementia most commonly reported practical, emotional and social impacts as the reasons why they most feared this condition. Almost all participants preferred to know the diagnosis of dementia as soon as possible for themselves, with significantly fewer preferring their spouse to know as soon as possible if they had dementia (95.9 % for self vs. 67.5 % for partner/spouse, p < 0.001). On average, participants estimated that 18.1 % of Japanese people are diagnosed with dementia by age 65, while they thought that 43.7 % of Japanese people are diagnosed with dementia by age 85. Conclusions: The findings highlight a need for community education about the significant impacts of dementia on the lives of individuals and their caregivers. People were more reluctant for their spouse to receive a diagnosis as soon as possible if they had dementia. Physicians should sensitively disclose diagnosis and ensure they involve both the patient and their relatives in discussions about diagnosis disclosure.]]> Wed 26 Oct 2022 15:35:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45108 Wed 26 Oct 2022 13:19:35 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45053 Wed 26 Oct 2022 12:04:50 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55201 90% of patients annually) and five practices with low rates of monitoring HbA1c levels (< 80% of patients annually) from HNELHD, NSW provided the sampling frame. A total of nine GPs were interviewed. The transcripts from the interviews were reviewed and analysed to identify emergent patterns and themes. Results: Overall, GPs were supportive of DAP. They considered that DAP resulted in significant changes in their knowledge, skills, and approach and improved the quality of diabetes care. Taking a more holistic approach to care, including assessing patients with diabetes for co-morbidities and risk factors that may impact on their future health was also noted. DAP was noted to increase the confidence levels of GPs, which enabled active involvement in the provision of diabetes care rather than referring patients for tertiary specialist care. However, some indicated the program could be time consuming and greater flexibility was needed. Conclusions: GPs reported DAP to benefit their knowledge, skills and approach for managing diabetes. Future research will need to investigate how to improve the intensity and flexibility of the program based on the workload of GPs to ensure long-term acceptability of the program.]]> Wed 24 Apr 2024 13:05:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38149 Wed 22 Mar 2023 17:27:13 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39767 Wed 22 Jun 2022 11:51:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50965 Wed 20 Mar 2024 14:56:43 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23839 Wed 19 Apr 2023 16:43:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50696 Wed 15 May 2024 14:51:17 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45365 Wed 13 Mar 2024 19:11:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52903 Wed 13 Mar 2024 19:07:30 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40280 Wed 13 Mar 2024 08:58:30 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45248 P < 0.05), but have no impact on average length of stay. Conclusions: China's fragmented urban health insurance schemes require further reform to ensure better equity in healthcare utilization and medical costs for stroke patients. Improving education attainment, offering equal access to healthcare, allocating health resources reasonably and balancing health services prices in different regions also count.]]> Wed 13 Mar 2024 08:53:14 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54789 Wed 13 Mar 2024 08:33:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50268 Wed 12 Jul 2023 12:19:07 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16776 Wed 11 Apr 2018 17:08:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15203 Wed 11 Apr 2018 16:56:38 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15176 Wed 11 Apr 2018 16:44:39 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14768 Wed 11 Apr 2018 16:32:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15668 Wed 11 Apr 2018 16:26:48 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14567 Wed 11 Apr 2018 16:06:32 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14771 Wed 11 Apr 2018 16:01:48 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15194 Wed 11 Apr 2018 15:37:49 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24920 3 care episodes (median 2); 35% stayed a total of >30 days in hospital (median 17); 42% were admitted to 2 or more different hospitals. Twelve percent of decedents spent time in an ICU with median 3 days. In the metropolitan area, 80% of decedents presented to an ED and 18% had >3 presentations. Overall 55% died in a hospital or inpatient hospice. Although we could not quantify the extent and type of palliative care, 24% had mention of "palliative care" in their records. The very elderly and those dying from diseases of the circulatory system or living in the least disadvantaged areas generally had lower hospital service use. Conclusions: These population-wide health data collections give a highly informative description of NSW hospital-based end-of-life service utilisation. Use of hospital-based services during the last year of life was common, with substantial variation across sociodemographic groups, especially defined by age, cause of death and socioeconomic classification of the decedents' place of residence. Further research is now needed to identify the contributors to these findings. Gaps in data collection were identified - particularly for palliative care and patient-reported outcomes. Addressing these gaps should facilitate improved monitoring and assessment of service use and care.]]> Wed 11 Apr 2018 15:25:07 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24041 Wed 11 Apr 2018 15:24:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24197 Wed 11 Apr 2018 15:09:02 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7837 Wed 11 Apr 2018 15:08:36 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9729 Wed 11 Apr 2018 14:55:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18895 0.2). Criteria for discriminant validity was not met, with only 10 of the 15 (67%) a-priori hypotheses supported. Test-retest reliability was acceptable for 40 of the 89 items (45%) and for three of the five domains. Significant floor effects were evident for all five domains. Conclusions: The SUNS demonstrates evidence for multiple features of validity and reliability as a measure of unmet needs for haematological cancer survivors. However, evidence supporting some psychometric properties was limited.]]> Wed 11 Apr 2018 14:52:48 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15143 Wed 11 Apr 2018 14:34:26 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15672 Wed 11 Apr 2018 14:11:59 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13534 Wed 11 Apr 2018 14:07:47 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15674 Wed 11 Apr 2018 13:33:40 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6945 Wed 11 Apr 2018 13:27:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15183 Wed 11 Apr 2018 13:22:59 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24530 Wed 11 Apr 2018 12:59:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25913 Wed 11 Apr 2018 12:48:18 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15170 Wed 11 Apr 2018 12:34:47 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29627 Wed 11 Apr 2018 11:29:36 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14797 Wed 11 Apr 2018 11:17:18 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20023 Wed 11 Apr 2018 11:10:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14813 Wed 11 Apr 2018 10:21:18 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6940 Wed 11 Apr 2018 09:50:28 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15205 Wed 11 Apr 2018 09:45:15 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55097 Wed 10 Apr 2024 08:45:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55222 Wed 01 May 2024 10:45:33 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49758 Tue 30 May 2023 18:03:39 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54057 Tue 30 Jan 2024 13:56:43 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54038 Tue 30 Jan 2024 13:41:40 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30204 Tue 28 Feb 2023 10:27:41 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35292 Tue 28 Feb 2023 10:21:40 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41416 Tue 28 Feb 2023 10:18:59 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54462 Tue 27 Feb 2024 14:00:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51992 Tue 26 Sep 2023 11:01:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16086 Tue 24 Aug 2021 14:28:01 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16097 Tue 24 Aug 2021 14:26:09 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24538 Tue 24 Aug 2021 14:23:29 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54314 Tue 20 Feb 2024 14:35:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37265 Tue 15 Sep 2020 13:05:19 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38510 Tue 12 Oct 2021 16:00:01 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39502 n = 28) out of 1006 audited records, and only 10 (1%) of them were legally binding. The number of EGs appointed was 39 (3.9%) across the sites. A total of 151 (15.4%) resuscitation plans were found across the eight hospital sites. 95% (n = 144) of the resuscitation plans indicated ‘Not-for-resuscitation’. Conclusions: The uptake of ACP is very low. Current medical recording system reveals the challenges in ACP lie in the process of storage, access and execution of the ACDs. Given that having an ACD or Enduring Guardian in place is only useful if the treating physician knows how and where to access the information, it has implications for policy, information system, and healthcare professionals’ education. Trial registration: The study was retrospectively registered with the Australian New Zealand Clinical Trials Registry (Trial ID: ACTRN12618001627246). The URL of the trial registry record http://www.anzctr.org.au/trial/MyTrial.aspx]]> Tue 09 Aug 2022 14:39:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41390 Tue 02 Aug 2022 17:40:31 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51321 Thu 31 Aug 2023 14:31:53 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52110 Thu 28 Sep 2023 14:56:39 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45313 Thu 27 Oct 2022 13:24:15 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36904 Thu 16 Jul 2020 12:54:43 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53654 Thu 14 Dec 2023 14:34:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29744 Thu 14 Apr 2022 11:01:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25771 Thu 13 Aug 2020 08:45:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30168 Thu 13 Aug 2020 08:45:11 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52606 Thu 08 Feb 2024 15:29:24 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52250 Thu 05 Oct 2023 14:07:25 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52208 Thu 05 Oct 2023 10:16:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32806 Thu 03 Feb 2022 12:20:53 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42707 Thu 01 Sep 2022 09:55:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43615 Mon 26 Sep 2022 16:01:51 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32820 Mon 23 Sep 2019 12:14:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31959 Mon 23 Sep 2019 11:55:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53257 Mon 20 Nov 2023 11:04:12 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53247 Mon 20 Nov 2023 10:15:38 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48929 Mon 17 Apr 2023 11:14:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47963 Mon 13 Feb 2023 15:30:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30995 Mon 12 Oct 2020 10:59:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54175 Mon 12 Feb 2024 09:35:09 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40085 Mon 08 Aug 2022 11:47:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48252 Mon 01 May 2023 10:30:09 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45474 Fri 28 Oct 2022 14:37:19 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45473 n = 1630), 4-months (n = 1677), and 9-months post-intervention (n = 1551). Intervention costs were based on trial records while labour costs were gathered from wage awards. Incremental cost effectiveness ratios were calculated for 4- and 9-months post-intervention and tested with non-parametric bootstrapping. Sensitivity scenarios recalculated results after adjusting costs and parameters. Results: The trial found reductions in catheterisations across the four hospitals between preintervention (12.0 % (10.4 − 13.5 %), n = 195) and the 4- (9.9 % (8.5 − 11.3 %), n = 166 ) and 9- months (10.2 % (8.7 − 11.7 %) n = 158) post-intervention points. The trend was statistically non-significant (p = 0.1). Only one diagnosed CAUTI case was observed across the surveys. However, statistically and clinically significant decreases in catheterisation rates occurred for medical and critical care wards, and among female patients and short-term catheterisations. Incremental cost effectiveness ratios at 4-months and 9-months post-intervention were $188 and $264. Bootstrapping found reductions in catheterisations at positive costs over at least 72 % of iterations. Sensitivity scenarios showed that cost effectiveness was most responsive to changes in catheterisation rates. Conclusions: Analysis showed that the association between the intervention and changes in catheterisation rates was not statistically significant. However, the intervention resulted in statistically significant reductions for subgroups including among short-term catheterisations and female patients. Cost-effectiveness analysis showed that reductions in catheterisations were most likely achieved at positive cost.]]> Fri 28 Oct 2022 14:36:39 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27085 40 medical patients each year were targeted to receive the intervention which consisted of a one-to-one educational visit on VTE prevention from a trained peer facilitator. The EOV protocol was designed by a multidisciplinary group of healthcare professionals using social marketing theory. Results: Nineteen (73%) of 26 eligible participants received an EOV. The majority (n = 16, 85%) felt the EOV was effective or extremely effective at increasing their knowledge about VTE prophylaxis and 15 (78%) gave a verbal commitment to provide evidence-based prophylaxis. The average length of each visit was 15 minutes (IQ range 15 to 20) and the average time spent arranging and conducting each visit was 92 minutes (IQ range 78 to 129). There was a significant improvement in the proportion of medical patients receiving appropriate pharmacological VTE prophylaxis following the intervention (54% to 70%, 16% improvement, 95% CI 5 to 26, p = 0.004). Conclusions: EOV is effective at improving doctors’ provision of pharmacological VTE prophylaxis to hospitalised medical patients. It was also found to be an acceptable implementation strategy by the majority of participants; however, it was resource intensive requiring on average 92 minutes per visit.]]> Fri 24 May 2019 12:29:42 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42289 Fri 19 Aug 2022 14:58:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49953 Fri 16 Jun 2023 13:49:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55281 Fri 10 May 2024 16:13:47 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51510 Fri 08 Sep 2023 12:04:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51371 Fri 01 Sep 2023 13:41:10 AEST ]]>